Efficiency of different strategies of asthma control achievement in real clinical practice Source: Annual Congress 2011 - Asthma: control and treatment Year: 2011
Effectiveness of different models of maintenance therapy for bronchial asthma (BA) in routine clinical practice Source: Eur Respir J 2007; 30: Suppl. 51, 70s Year: 2007
Evaluation of efficacy and safety of budesonide/formeterol combination therapy in asthma patients Source: Eur Respir J 2006; 28: Suppl. 50, 314s Year: 2006
The effectiveness of different clinical measures in evaluating response to omalizumab Source: Annual Congress 2010 - Questionnaires use and psychological aspects in asthma Year: 2010
Less is more: the impact of maintenance treatment adherence in severe asthma clinical trials Source: Eur Respir J, 53 (5) 1900599; 10.1183/13993003.00599-2019 Year: 2019
Clinical and economic impact of an improvement in adherence based on specific attributes of single-inhaler triple therapies in COPD patients Source: International Congress 2019 – Inhalers: adherence and preference Year: 2019
Assessing the effect of medical therapy in COPD: from pathophysiology and biomarkers to clinical practice Source: Annual Congress 2009 - PG15 The complexity of COPD: assessment and advanced therapies Year: 2009
Comparative assessment of the qol specific parameters in children with bronchial asthma with standard pharmacotherapy, and in additional course of physiotherapy in the pool Source: International Congress 2018 – Pulmonary rehabilitation: exercise training, body composition, physical activity and other aspects Year: 2018
Is there a place for anti-remodelling drugs in asthma which may not display immediate clinical efficacy? Source: Eur Respir J 2004; 24: 1-2 Year: 2004
New and future developments of therapy for asthma in children Source: Eur Respir Mon 2012; 56: 224-234 Year: 2012
Effectiveness versus efficacy trials in COPD: how study design influences outcomes and applicability Source: Eur Respir J, 51 (2) 1701531; 10.1183/13993003.01531-2017 Year: 2018
Factors that determine the success of step-up therapy in uncontrolled asthmatic patients in clinical practice Source: International Congress 2018 – Clinical markers of asthma Year: 2018
SABINA: global programme to evaluate prescriptions and clinical outcomes related to short-acting ß2 -agonist use in asthma Source: Eur Respir J, 55 (2) 1901858; 10.1183/13993003.01858-2019 Year: 2020
Cost-effectiveness analysis of asthma treatment strategies Source: Annual Congress 2008 - Rationale of self-education in asthma therapy Year: 2008
Measuring airway hyperresponsiveness: does it add to routine measures of clinical efficacy in guiding asthma therapy? Source: Eur Respir J 2006; 28: Suppl. 50, 319s Year: 2006
Evaluation of prophylactic observations efficacy and the quality of TB treatment using a math model for primarily revealed patients Source: Eur Respir J 2004; 24: Suppl. 48, 722s Year: 2004
Budesonide/formoterol maintenance and reliever therapy for asthma compared to conventional best practice: a randomised real-life study Source: Eur Respir J 2006; 28: Suppl. 50, 613s Year: 2006
Budesonide/formoterol for maintenance and as needed — a new approach to asthma management in children Source: Eur Respir J 2005; 26: Suppl. 49, 161s Year: 2005
Physician assessment of asthma control in patients receiving omalizumab in a real-world setting Source: Annual Congress 2012 - Asthma treatment: efficacy and safety Year: 2012